News Vaxxas announces CEPI partnership to advance needle-free mRN... Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidem
R&D Keeping the pandemic at bay with needle-free vaccine deliver... COVID-19 is still circulating and there are fears that further spikes in cases are to be expected in the coming months.
News GSK wagers $750m on Chimagen multiple myeloma therapy GSK has continued a drive to bulk up its pipeline, taking global rights to a T-cell engager for multiple myeloma, developed by China's Chimagen Bio.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
